BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1762167)

  • 1. [Clinical evaluation of cefdinir 5% fine granules in pediatrics].
    Iwai N; Nakamura H; Taneda Y; Miyazu M; Kasai K; Watanabe Y
    Jpn J Antibiot; 1991 Oct; 44(10):1096-118. PubMed ID: 1762167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1991 Oct; 44(10):1119-33. PubMed ID: 1762168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic, bacteriological and clinical studies on cefdinir fine granules in the field of pediatrics].
    Haruta T; Kuroki S; Okura K; Yoshida N; Kobayashi Y
    Jpn J Antibiot; 1991 Oct; 44(10):1158-67. PubMed ID: 1762171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies of cefdinir in pediatric infections].
    Shinozaki T
    Jpn J Antibiot; 1991 Oct; 44(10):1087-95. PubMed ID: 1762166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and clinical effects of cefdinir 5% fine granules in pediatrics].
    Motohiro T; Handa S; Yamada S; Oki S; Tsumura N; Yoshinaga Y; Aramaki M; Shimada Y; Kawakami A; Koga T
    Jpn J Antibiot; 1990 Oct; 43(10):1813-35. PubMed ID: 2086819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Takajo N; Okabayashi S
    Jpn J Antibiot; 1992 Dec; 45(12):1700-35. PubMed ID: 1289589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on 10% cefdinir granules in pediatric infections].
    Niinou K; Nakazawa S; Sato H
    Jpn J Antibiot; 1991 Oct; 44(10):1069-75. PubMed ID: 1762163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and clinical effects of cefdinir 10% fine granules in pediatrics].
    Motohiro T; Handa S; Yamada S; Oki S; Tsumura N; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Kawakami A
    Jpn J Antibiot; 1992 Jan; 45(1):74-86. PubMed ID: 1495197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on cefprozil in pediatrics].
    Iwai N; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1992 Nov; 45(11):1537-57. PubMed ID: 1494236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
    Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
    Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1991 Oct; 44(10):1142-57. PubMed ID: 1762170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory and clinical studies on cefdinir (10% fine granules) in pediatric field].
    Kuno K; Ogawa A; Takeuchi H; Tomita K; Kitoh O; Andoh H; Takimoto Y
    Jpn J Antibiot; 1991 Oct; 44(10):1134-41. PubMed ID: 1762169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cefdinir 10% granules in children].
    Meguro H; Mori A; Fujii R; Terashima I
    Jpn J Antibiot; 1991 Oct; 44(10):1061-8. PubMed ID: 1762162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam].
    Fujii R; Abe T; Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Kusumoto Y; Iwata S; Satoh Y; Toyonaga Y; Ishihara T; Nakamura H; Iwai N; Nakamura H; Kuno K; Katoh T; Ogawa A; Itomi K; Okumura A; Hayakawa F; Takahashi H; Etoh M
    Jpn J Antibiot; 1997 Jul; 50(7):597-621. PubMed ID: 9743906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical evaluation of cefdinir in pediatric infections].
    Katsushima N; Sakamoto M
    Jpn J Antibiot; 1990 Aug; 43(8):1436-41. PubMed ID: 2283713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on cefprozil granules].
    Haruta T; Tsutsui T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1992 Dec; 45(12):1642-9. PubMed ID: 1289582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic and clinical studies of S-1108 in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Sano T; Nakamura H
    Jpn J Antibiot; 1993 Nov; 46(11):991-1002. PubMed ID: 8309075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.